Alqahtani, S., Cacace, F., McMichael, T., Dodd, E., McCarthy, E., Bauchat, A., … Mahadeo, K. M. (2024). Cultured Thymus Tissue Implantation for Congenital Athymia Post FDA Approval: Auto-Immunity and Novel Genetic Mutations. In Blood (Vol. 144, pp. 1158–1158). American Society of Hematology. https://doi.org/10.1182/blood-2024-211756

Alqahtani, Shaikha, Fabiana Cacace, Taylor McMichael, Emily Dodd, Elizabeth McCarthy, Andrea Bauchat, Timothy A. Driscoll, et al. “Cultured Thymus Tissue Implantation for Congenital Athymia Post FDA Approval: Auto-Immunity and Novel Genetic Mutations.” In Blood, 144:1158–1158. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-211756.

Alqahtani S, Cacace F, McMichael T, Dodd E, McCarthy E, Bauchat A, et al. Cultured Thymus Tissue Implantation for Congenital Athymia Post FDA Approval: Auto-Immunity and Novel Genetic Mutations. In: Blood. American Society of Hematology; 2024. p. 1158–1158.

Alqahtani, Shaikha, et al. “Cultured Thymus Tissue Implantation for Congenital Athymia Post FDA Approval: Auto-Immunity and Novel Genetic Mutations.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 1158–1158. Crossref, doi:10.1182/blood-2024-211756.

Alqahtani S, Cacace F, McMichael T, Dodd E, McCarthy E, Bauchat A, Driscoll TA, Martin PL, Bonfim C, Sleasman J, Mahadeo KM. Cultured Thymus Tissue Implantation for Congenital Athymia Post FDA Approval: Auto-Immunity and Novel Genetic Mutations. Blood. American Society of Hematology; 2024. p. 1158–1158.